Vanguard Therapeutics is an early stage California company that is developing a disease changing, orally absorbable, cell adhesion-blocking drug for prophylactic therapy of sickle cell disease (SCD).
Company (Alive / Active)
108 Eagle Trace Drive
Half Moon Bay, 94019
California, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)